Back
Gilead Sciences Quote, Financials, Valuation and Earnings
Sell
30
GILD
Gilead Sciences
Last Price:
67.86
Seasonality Move:
6.01%
7 Day Trial
ALL ACCESS PASS
$
7
Gilead Sciences Price Quote
$67.86
+0.85 (+1.27%)
(Updated: May 16, 2024 at 1:20 PM ET)
Gilead Sciences Key Stats
Sell
30
Gilead Sciences (GILD)
is a Sell
Day range:
$66.97 - $67.98
52-week range:
$64.33 - $87.87
Dividend yield:
4.51%
P/E ratio:
14.89
P/S ratio:
3.06
P/B ratio:
4.76%
Volume:
6.5M
Avg. volume:
7.1M
1-year change:
-14.51%
Market cap:
$83.5B
Revenue:
$27.1B
EPS:
$0.36
How Much Does Gilead Sciences Make?
-
How Much Are Gilead Sciences's Sales Annually?
GILD Revenues are $27.1B -
How Much Profit Does Gilead Sciences's Make A Year?
GILD net income is $5.7B
Is Gilead Sciences Growing As A Company?
-
What Is Gilead Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.05% -
What Is Gilead Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Gilead Sciences Stock Price Performance
-
Did Gilead Sciences Stock Go Up Last Month?
Gilead Sciences share price went down by -1.09% last month -
Did GILD's Share Price Rise Over The Last Year?
GILD share price fell by -14.51% over the past 1 year
What Is Gilead Sciences 52-Week High & Low?
-
What Is Gilead Sciences’s 52-Week High Share Price?
Gilead Sciences has traded as high as $87.87 over the past 52 weeks -
What Is Gilead Sciences’s 52-Week Low Share Price?
Gilead Sciences has traded as low as $64.33 over the past 52 weeks
Gilead Sciences Price To Free Cash Flow
-
Is Gilead Sciences Stock Overvalued?
Gilead Sciences is trading at a price to free cash flow ratio of 10.64 -
Is Gilead Sciences Stock Undervalued?
Gilead Sciences EV to Free Cash Flow ratio is 13.15 -
What Is Gilead Sciences’s Price Earnings Growth Ratio?
GILD PEG ratio is 0.00 -
Is Gilead Sciences Trading At A Premium To Earnings?
Gilead Sciences EV to EBIT ratio is 50.90
Is It Risky To Buy Gilead Sciences?
-
How Much Debt Does Gilead Sciences Have?
Total long term debt quarterly is $25.2B -
How Much Cash Does Gilead Sciences Have?
Cash and short term investments quarterly total is $4.7B -
What Is Gilead Sciences’s Book Value Per Share?
Book value per share is 14.07
Is Gilead Sciences Cash Flow Positive?
-
What Is GILD Cash Flow From Operations?
Cash flow from operations (TTM) is $8.5B -
What Is Gilead Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$5.1B -
What Is Gilead Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.6B
Gilead Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
GILD return on invested capital is 1.05% -
What Is Gilead Sciences Return On Assets?
ROA measures how assets are converting to revenues and is 0.79% -
What Is GILD Return On Equity?
ROE is a measure of profitability and is 2.32%
Gilead Sciences Earnings Date & Stock Price
-
What Is Gilead Sciences's Stock Price Today?
A single share of GILD can be purchased today for 67.01 -
What Is Gilead Sciences’s Stock Symbol?
Gilead Sciences trades on the S&P500 under the ticker symbol: GILD -
When Is Gilead Sciences’s Next Earnings Date?
The next quarterly earnings date for Gilead Sciences is scheduled on August 2, 2024 -
When Is GILD's next ex-dividend date?
Gilead Sciences's next ex-dividend date is June 14, 2024 -
How To Buy Gilead Sciences Stock?
You can buy Gilead Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Gilead Sciences Competitors
-
Who Are Gilead Sciences's Competitors?
Below is a list of companies who compete with Gilead Sciences or are related in some way:
Gilead Sciences Dividend Yield
-
What Is GILD Dividend Yield?
Gilead Sciences’s dividend yield currently is 4.51% -
What Is Gilead Sciences’s Payout Ratio?
Gilead Sciences’s payout ratio is 791.32% -
When Did Gilead Sciences Last Pay A Dividend?
The latest dividend pay date is May 16, 2024 -
What Is Gilead Sciences’s Dividend Per Share?
Gilead Sciences pays a dividend of $0.77 per share
Gilead Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 13.11% |
Revenue: | 5.26% | 5.31% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 17 |
Sell Recommendations: | 0 |
Price Target: | 82.93 |
Upside from Last Price: | 23.76% |